NEW YORK, April 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). Shareholders who purchased shares of EVLV during the class period listed are encouraged to contact the firm regarding possible lead…
Month: April 2024
NEW YORK, April 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of DICK’s Sporting Goods (NYSE: DKS). Shareholders who purchased shares of DKS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
NEW YORK, April 12, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Plug Power Inc. (NASDAQ: PLUG). Shareholders who purchased shares of PLUG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff…
DUBAI, UAE, April 12, 2024 /PRNewswire/ — OKX, a leading crypto exchange and Web3 technology company, has issued updates for April 12, 2024. OKX Lists Linea’s FOXY on its Spot Market OKX today listed FOXY on its spot market at 8:00 AM (UTC). This addition enables users to trade FOXY…
NEW YORK, April 12, 2024 /PRNewswire/ — The global intellectual property software market size is estimated to grow by USD 5.64 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.93% during the forecast period. The intellectual property…
A recently released report, ‘State of Expense Management 2024’, sheds light on the evolving practices in expense management. It emphasises the critical shift towards digital solutions and the broadening of expense management responsibilities across organisations in six European countries….
H2 HPDITM, notre solution rentable et performante pour soutenir la neutralité climatique dans le secteur de la mobilité des poids lourds, sera en mesure d’atteindre la classification VZE pour de nombreuses configurations de camions VANCOUVER, Colombie-Britannique, 12 avril 2024…
STOCKHOLM, April 12, 2024 /PRNewswire/ — Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events have been reported, and no patients have discontinued the trial. “This is an important milestone in…
SINGAPORE, April 12, 2024 /PRNewswire/ — OKX, a leading Web3 technology company, has issued updates for April 12, 2024. OKX to Soon Support Metaplex Core Token Standard on NFT Marketplace OKX’s multi-chain, zero-fee NFT Marketplace will soon introduce support for the Metaplex Core token…
STOCKHOLM, April 12, 2024 /PRNewswire/ — Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events have been reported, and no patients have discontinued the trial. “This is an important milestone in…